NCT04591925View on ClinicalTrials.gov

SteadiSet™ Pilot Study (SteP Study)

NATerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 5, 2021

Primary Completion Date

November 2, 2021

Study Completion Date

November 2, 2021

Conditions
Diabetes Mellitus, Type IIDDMDiabetes Mellitus, Insulin-Dependent, 1Type 1 DiabetesType 1 Diabetes Mellitus
Interventions
DEVICE

Control Device insulin infusion devcie

Control Device - Commercially available insulin infusion device using a soft Teflon indwelling cannula

DEVICE

Investigative insulin infusion devcie

Investigative insulin infusion device with coil-reinforced soft polymer indwelling cannula

Trial Locations (1)

8036

Medizinische Universität Graz, Graz

Sponsors
All Listed Sponsors
lead

Capillary Biomedical, Inc.

INDUSTRY

NCT04591925 - SteadiSet™ Pilot Study (SteP Study) | Biotech Hunter | Biotech Hunter